Hot Features
プレミアム
登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-22 | Mr. Brenton L. SaundersCEO & Chairman | -2.89k | 45.95k | Sale to Issuer | 15.92 | 425.67k | -0.67% |
| 2026-05-22 | Mr. Brenton L. SaundersCEO & Chairman | 4.45k | 70.80k | Derivative Exercise and Retained Stock | 15.92 | 425.67k | 1.06% |
| 2026-05-19 | Ms. Karen L. LingIndependent Director | 20.34k | 329.48k | Derivative Exercise and Retained Stock | 16.20 | 41.68k | 95.31% |
| 2026-05-05 | Mr. Osama A. EldessoukyExec. VP & CFO | 61.06k | 976.99k | Derivative Exercise and Retained Stock | 16.00 | 201.00k | 43.64% |
| 2026-05-05 | Dr. Yehia HashadExec. VP of Research & Development and Chief Medical officer | 21.06k | 336.93k | Derivative Exercise and Retained Stock | 16.00 | 107.52k | 24.35% |
| 2026-05-05 | Mr. Frederick J. MunschSenior VP, Controller & CAO | 13.55k | 216.78k | Derivative Exercise and Retained Stock | 16.00 | 52.94k | 34.40% |
| 2026-05-05 | Mr. Luc BonnefoyPresident of Surgical | 9.25k | 148.03k | Derivative Exercise and Retained Stock | 16.00 | 34.66k | 36.41% |
| 2026-05-05 | Mr. Thomas J. Appioインサイダー | 27.58k | 441.33k | Derivative Exercise and Retained Stock | 16.00 | 27.58k | - |
| 2026-05-05 | Mr. Osama A. EldessoukyExec. VP & CFO | -63.94k | 1.02M | Sale to Issuer | 16.00 | 343.19k | -15.70% |
| 2026-05-05 | Dr. Yehia HashadExec. VP of Research & Development and Chief Medical officer | -13.66k | 218.62k | Sale to Issuer | 16.00 | 166.38k | -7.59% |
| 2026-05-05 | Mr. Frederick J. MunschSenior VP, Controller & CAO | -8.67k | 138.77k | Sale to Issuer | 16.00 | 89.64k | -8.82% |
| 2026-05-05 | Mr. Luc BonnefoyPresident of Surgical | -11.97k | 191.52k | Sale to Issuer | 16.00 | 88.03k | -11.97% |
| 2026-04-24 | Mr. Andrew J. StewartPresident of Global Pharmaceuticals & International Consumer | -4.22k | 66.70k | Sale to Issuer | 15.82 | 32.52k | -11.48% |
| 2026-04-24 | Mr. A. Robert D. BaileyExec. VP & Chief Legal Officer | -15.81k | 250.05k | Sale to Issuer | 15.82 | 125.30k | -11.20% |
| 2026-04-24 | Mr. A. Robert D. BaileyExec. VP & Chief Legal Officer | 24.36k | 385.39k | Derivative Exercise and Retained Stock | 15.82 | 125.30k | 24.13% |
| 2026-04-24 | Mr. A. Robert D. BaileyExec. VP & Chief Legal Officer | -15.81k | 0.00 | Derivative Exercise and Sale | 15.82 | 125.30k | - |
| 2026-04-24 | Mr. Andrew J. StewartPresident of Global Pharmaceuticals & International Consumer | 11.05k | 174.81k | Derivative Exercise and Retained Stock | 15.82 | 32.51k | 51.48% |
| 2026-04-24 | Mr. Andrew J. StewartPresident of Global Pharmaceuticals & International Consumer | -4.22k | 66.70k | 売り | 15.82 | 32.51k | -11.48% |
| 2026-03-06 | Mr. A. Robert D. BaileyExec. VP & Chief Legal Officer | 14.60k | 250.33k | 買い | 17.15 | 100.94k | 16.91% |
| 2026-03-06 | Mr. Osama A. EldessoukyExec. VP & CFO | 4.00k | 68.52k | 買い | 17.13 | 139.94k | 2.94% |
| 2026-03-06 | Mr. Brenton L. SaundersCEO & Chairman | 14.70k | 251.96k | 買い | 17.14 | 421.22k | 3.62% |
| 2026-03-06 | Mr. Brenton L. SaundersCEO & Chairman | 727.00 | 12.46k | 買い | 17.10 - 17.16 | 421.22k | 0.17% |
| 2026-03-06 | Mr. A. Robert D. BaileyExec. VP & Chief Legal Officer | 14.60k | 250.34k | 買い | 17.10 - 17.20 | 100.94k | 16.91% |
| 2026-03-06 | Mr. Osama A. EldessoukyExec. VP & CFO | 4.00k | 68.52k | 買い | 17.13 | 139.94k | 2.94% |
| 2026-03-06 | Mr. Brenton L. SaundersCEO & Chairman | 18.79k | 311.04k | 買い | 12.55 - 17.19 | 421.22k | 4.67% |
| 2026-03-03 | Mr. Thomas Warren RossLead Independent Director | 4.50k | 79.56k | 買い | 17.68 | 44.55k | 11.24% |
| 2026-03-03 | Mr. Thomas Warren RossLead Independent Director | 950.00 | 16.79k | 買い | 17.67 | 17.00k | 5.92% |
| 2026-03-02 | Dr. Eduardo C. AlfonsoIndependent Director | 4.30k | 76.97k | 買い | 17.90 | 4.30k | - |
| 2026-02-27 | Dr. Andrew C. von EschenbachIndependent Director | 4.36k | 79.88k | 買い | 18.31 | 46.11k | 10.45% |
| 2026-02-27 | Mr. Osama A. EldessoukyExec. VP & CFO | 113.10k | 2.07M | Derivative Exercise and Retained Stock | 18.30 | 135.94k | 495.14% |
| 2026-02-27 | Mr. Osama A. EldessoukyExec. VP & CFO | -51.47k | 941.90k | 売り | 18.30 | 135.94k | -27.46% |
| 2026-02-27 | Dr. Yehia HashadExec. VP of Research & Development and Chief Medical officer | 47.12k | 862.31k | Derivative Exercise and Retained Stock | 18.30 | 86.47k | 119.77% |
| 2026-02-27 | Dr. Yehia HashadExec. VP of Research & Development and Chief Medical officer | -11.62k | 212.66k | 売り | 18.30 | 86.47k | -11.85% |
| 2026-02-27 | Mr. Frederick J. MunschSenior VP, Controller & CAO | 20.03k | 366.49k | Derivative Exercise and Retained Stock | 18.30 | 39.39k | 103.43% |
| 2026-02-27 | Mr. Frederick J. MunschSenior VP, Controller & CAO | -5.69k | 104.16k | 売り | 18.30 | 39.39k | -12.63% |
| 2026-02-27 | Mr. Luc BonnefoyPresident of Surgical | 16.35k | 299.17k | Derivative Exercise and Retained Stock | 18.30 | 25.41k | 180.40% |
| 2026-02-27 | Mr. Luc BonnefoyPresident of Surgical | -9.22k | 168.74k | 売り | 18.30 | 25.41k | -26.63% |
| 2026-02-27 | Dr. Andrew C. von EschenbachIndependent Director | 4.36k | 79.88k | 買い | 18.31 | 18.56k | 30.74% |
| 2026-03-02 | Dr. Eduardo C. AlfonsoIndependent Director | 4.30k | 76.97k | 買い | 17.90 | 4.30k | - |
| 2026-02-26 | Mr. Frederick J. MunschSenior VP, Controller & CAO | -10.17k | 186.52k | Sale to Issuer | 18.30 - 18.49 | 39.08k | -20.65% |
| 2026-02-26 | Mr. Andrew J. StewartPresident of Global Pharmaceuticals & International Consumer | -4.99k | 91.90k | Sale to Issuer | 18.30 - 18.49 | 25.68k | -16.27% |
| 2026-02-26 | Mr. Luc BonnefoyPresident of Surgical | -17.94k | 329.07k | Sale to Issuer | 18.30 - 18.49 | 28.24k | -38.85% |
| 2026-02-26 | Dr. Yehia HashadExec. VP of Research & Development and Chief Medical officer | -18.87k | 345.64k | Sale to Issuer | 18.30 - 18.49 | 68.16k | -21.68% |
| 2026-02-26 | Mr. Brenton L. SaundersCEO & Chairman | 575.90k | 10.59M | Derivative Exercise and Retained Stock | 18.30 - 18.49 | 406.52k | -340.00% |
| 2026-02-26 | Mr. Brenton L. SaundersCEO & Chairman | -373.66k | 984.20 | Derivative Exercise and Sale | 18.30 - 18.49 | 406.52k | - |
| 2026-02-26 | Mr. A. Robert D. BaileyExec. VP & Chief Legal Officer | 18.84k | 346.75k | Derivative Exercise and Retained Stock | 18.30 - 18.49 | 86.34k | 27.92% |
| 2026-02-26 | Mr. A. Robert D. BaileyExec. VP & Chief Legal Officer | -5.86k | 0.00 | Derivative Exercise and Sale | 18.30 - 18.49 | 86.34k | - |
| 2026-02-26 | Mr. Osama A. EldessoukyExec. VP & CFO | 167.00k | 3.07M | Derivative Exercise and Retained Stock | 18.30 - 18.49 | 74.31k | -180.17% |
| 2026-02-26 | Mr. Osama A. EldessoukyExec. VP & CFO | -121.71k | 14.82 | Derivative Exercise and Sale | 18.30 - 18.49 | 74.31k | - |
| 2026-02-26 | Dr. Yehia HashadExec. VP of Research & Development and Chief Medical officer | 82.80k | 1.52M | Derivative Exercise and Retained Stock | 18.30 - 18.49 | 50.97k | -260.09% |
| 2026-02-26 | Dr. Yehia HashadExec. VP of Research & Development and Chief Medical officer | -38.70k | 58.90 | Derivative Exercise and Sale | 18.30 - 18.49 | 50.97k | - |
| 2026-02-26 | Mr. Frederick J. MunschSenior VP, Controller & CAO | 51.91k | 954.55k | Derivative Exercise and Retained Stock | 18.30 - 18.49 | 25.05k | -193.28% |
| 2026-02-26 | Mr. Frederick J. MunschSenior VP, Controller & CAO | -23.77k | 504.64 | Derivative Exercise and Sale | 18.30 - 18.49 | 25.05k | - |
| 2026-02-26 | Mr. Andrew J. StewartPresident of Global Pharmaceuticals & International Consumer | 67.27k | 1.24M | Derivative Exercise and Retained Stock | 18.30 - 18.49 | 25.68k | -161.74% |
| 2026-02-26 | Mr. Andrew J. StewartPresident of Global Pharmaceuticals & International Consumer | -39.93k | 371.26 | Derivative Exercise and Sale | 18.30 - 18.49 | 25.68k | - |
| 2026-02-27 | Mr. Luc BonnefoyPresident of Surgical | 5.59k | 102.35k | Derivative Exercise and Retained Stock | 18.30 | 18.28k | 44.07% |
| 2026-02-26 | Mr. Luc BonnefoyPresident of Surgical | -19.71k | 44.32k | Derivative Exercise and Sale | 18.30 - 18.49 | 18.28k | - |
| 2026-02-26 | Mr. Luc BonnefoyPresident of Surgical | -1.06k | 19.18k | 売り | 18.30 - 18.49 | 18.28k | -5.48% |
| 2026-02-26 | Mr. A. Robert D. BaileyExec. VP & Chief Legal Officer | -5.86k | 107.81k | Sale to Issuer | 18.30 - 18.49 | 86.34k | -6.35% |
| 2026-02-26 | Mr. Osama A. EldessoukyExec. VP & CFO | -74.04k | 1.36M | Sale to Issuer | 18.30 - 18.49 | 133.67k | -35.65% |
| 2026-02-26 | Mr. Brenton L. SaundersCEO & Chairman | -46.71k | 858.95k | Sale to Issuer | 18.30 - 18.49 | 406.52k | -10.31% |
| 2026-02-23 | Mr. Brenton L. SaundersCEO & Chairman | -65.44k | 1.18M | Sale to Issuer | 17.99 | 334.53k | -16.36% |
| 2026-02-23 | Mr. Brenton L. SaundersCEO & Chairman | 122.06k | 0.00 | Derivative Exercise and Retained Stock | - | 334.53k | 57.44% |
| 2026-02-23 | Mr. Brenton L. SaundersCEO & Chairman | -65.44k | 1.18M | Derivative Exercise and Sale | 17.99 | 334.53k | - |
| 2026-02-23 | Mr. Steven H. CollisIndependent Director | 15.00k | 267.15k | 買い | 17.81 | 15.00k | - |
| 2026-02-20 | Mr. Russel C. RobertsonIndependent Director | 4.40k | 78.76k | 買い | 17.90 | 10.21k | 75.76% |
| 2026-02-23 | Mr. Steven H. CollisIndependent Director | 15.00k | 267.15k | 買い | 17.81 | 15.00k | - |
| 2026-02-20 | Mr. Russel C. RobertsonIndependent Director | 4.40k | 78.76k | 買い | 17.90 | 10.21k | 75.76% |
| 2026-02-19 | Ms. Karen L. LingIndependent Director | 4.00k | 70.97k | 買い | 17.74 | 21.34k | 23.07% |
| 2026-02-19 | Ms. Karen L. LingIndependent Director | 4.00k | 70.97k | 買い | 17.74 | 21.34k | 23.07% |
| 2025-12-09 | Bausch Health Companies Inc.法人 | -26.50M | 0.00 | Other Disposition | - | 310.45M | -7.86% |
| 2025-04-02 | Bausch Health Companies Inc.法人 | -10.12M | 0.00 | Other Disposition | - | 310.45M | -3.16% |
| 2025-08-05 | Mr. Brenton L. SaundersCEO & Chairman | -4.23k | 61.10k | Sale to Issuer | 14.44 | 399.98k | -1.05% |
| 2025-07-25 | Dr. Yehia HashadExec. VP of Research & Development and Chief Medical officer | -2.84k | 40.68k | Sale to Issuer | 14.32 | 71.63k | -3.82% |
| 2025-07-25 | Mr. Luc BonnefoyPresident of Surgical | -2.17k | 31.03k | Sale to Issuer | 14.32 | 28.77k | -7.00% |
| 2025-07-25 | Mr. Frederick J. MunschSenior VP, Controller & CAO | -1.09k | 15.61k | Sale to Issuer | 14.32 | 36.99k | -2.86% |
| 2025-07-25 | Mr. Osama A. EldessoukyExec. VP & CFO | -4.00k | 57.22k | Sale to Issuer | 14.32 | 171.11k | -2.28% |
| 2025-06-13 | Mr. Luc BonnefoyPresident of Surgical | -968.00 | 11.94k | Sale to Issuer | 12.33 | 30.94k | -3.03% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
